NasdaqGS - Nasdaq Real Time Price USD

MiniMed Group, Inc. (MMED)

20.26 +0.16 (+0.80%)
At close: August 31 at 4:00:01 PM EDT
20.64 +0.38 (+1.88%)
Pre-Market: 4:00:04 AM EDT
MMED Q1 2027 earnings call
Today at 8:45 AM EDT
Chart Range Bar
Loading chart for MMED
  • Previous Close 20.10
  • Open 19.97
  • Bid 20.17 x 100
  • Ask 25.49 x 200
  • Day's Range 19.72 - 20.36
  • 52 Week Range 10.65 - 20.88
  • Volume 2,480,697
  • Avg. Volume 1,197,142
  • Market Cap (intraday) 5.7B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -1.31
  • Earnings Date Sep 1, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 20.83

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services. It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. MiniMed Group, Inc. operates as a subsidiary of Medtronic plc.

www.minimed.com

8,000

Full Time Employees

April 24

Fiscal Year Ends

Performance Overview

Trailing total returns as of 8/31/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MMED
6.35%
S&P 500 (^GSPC)
12.28%

1-Year Return

MMED
6.35%
S&P 500 (^GSPC)
18.98%

3-Year Return

MMED
6.35%
S&P 500 (^GSPC)
70.51%

5-Year Return

MMED
6.35%
S&P 500 (^GSPC)
69.95%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY26
Revenue 837M
Earnings -185M
Profit Margin -22.10%

Q3

FY26

Q4

FY26

0
200M
400M
600M
800M
-22.0%
-20.0%
-18.0%
-16.0%
 

Analyst Insights

View More

Analyst Price Targets

15.00 Low
20.83 Average
20.26 Current
25.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Latest Rating

Date 6/4/2026
Analyst Wells Fargo
Rating Action Maintains
Rating Overweight
Price Action Lowers
Price Target 26 -> 22
 

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    5.49B

  • Enterprise Value

    5.33B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.61

  • Price/Book (mrq)

    1.52

  • Enterprise Value/Revenue

    1.72

  • Enterprise Value/EBITDA

    92.94

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -10.73%

  • Return on Assets (ttm)

    1.73%

  • Return on Equity (ttm)

    -9.13%

  • Revenue (ttm)

    3.1B

  • Net Income Avi to Common (ttm)

    -333M

  • Diluted EPS (ttm)

    -1.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    298M

  • Total Debt/Equity (mrq)

    1.47%

  • Levered Free Cash Flow (ttm)

    -71.75M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

20.26 Current
 

Dividend Score

0 Low
Sector Avg.
100 High
 

Hiring Score

0 Low
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
Sector Avg.
100 High
 

People Also Watch